Perfil
Michelle Cuccia is currently the Chief Executive Officer at VAYA Pharma, Inc. and Vice President-Marketing at Enzymotec Ltd. She previously worked as Vice President-Marketing at Teva Pharmaceutical Industries Ltd. Ms. Cuccia has a graduate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Cornell University.
Cargos activos de Michelle Cuccia
| Empresas | Cargo | Inicio |
|---|---|---|
| ENZYMOTEC LTD. | Ventas & Marketing | 01/08/2017 |
VAYA Pharma, Inc.
VAYA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development, manufacture and marketing of natural lipids based medicines | Director Ejecutivo | 01/08/2017 |
Antiguos cargos conocidos de Michelle Cuccia.
| Empresas | Cargo | Fin |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Ventas & Marketing | - |
Formación de Michelle Cuccia.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enzymotec Ltd.
Enzymotec Ltd. BiotechnologyHealth Technology Develops, manufactures and markets lipid-based bioactive ingredients | Health Technology |
VAYA Pharma, Inc.
VAYA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development, manufacture and marketing of natural lipids based medicines | Health Technology |
- Bolsa de valores
- Insiders
- Michelle Cuccia
















